Caplin Point Laboratories Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Caplin Point Laboratories has a total shareholder equity of ₹23.5B and total debt of ₹19.7M, which brings its debt-to-equity ratio to 0.08%. Its total assets and total liabilities are ₹27.0B and ₹3.5B respectively. Caplin Point Laboratories's EBIT is ₹5.2B making its interest coverage ratio 943.1. It has cash and short-term investments of ₹7.9B.
Anahtar bilgiler
0.08%
Borç/özkaynak oranı
₹19.70m
Borç
| Faiz karşılama oranı | 943.1x |
| Nakit | ₹7.91b |
| Eşitlik | ₹23.47b |
| Toplam yükümlülükler | ₹3.51b |
| Toplam varlıklar | ₹26.98b |
Son finansal sağlık güncellemeleri
Recent updates
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 31
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Due To Pay A Dividend Of ₹2.50
Sep 12Earnings Update: Here's Why Analysts Just Lifted Their Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Price Target To ₹1,764
Aug 11Caplin Point Laboratories (NSE:CAPLIPOINT) Is Paying Out A Dividend Of ₹2.50
Aug 10Investors Aren't Buying Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Earnings
Jul 12Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues
May 24Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?
May 04Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement
Mar 07With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 24Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise
Sep 15Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50
Aug 11We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise
Sep 23Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 11Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?
Jul 22Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00
May 15A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Jan 21Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?
Oct 20Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50
Sep 17Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50
Sep 03Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price
Aug 27Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?
Jun 12Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Apr 29Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?
Mar 24Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: CAPLIPOINT's short term assets (₹18.9B) exceed its short term liabilities (₹3.3B).
Uzun Vadeli Yükümlülükler: CAPLIPOINT's short term assets (₹18.9B) exceed its long term liabilities (₹200.1M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: CAPLIPOINT has more cash than its total debt.
Borcun Azaltılması: CAPLIPOINT's debt to equity ratio has increased from 0.05% to 0.08% over the past 5 years.
Borç Kapsamı: CAPLIPOINT's debt is well covered by operating cash flow (16161.9%).
Faiz Kapsamı: CAPLIPOINT's interest payments on its debt are well covered by EBIT (943.1x coverage).